Selected Publications
Fesnak, A: T Cell and Related Immunotherapies Transfusion Medicine and Hemostasis: Clinical and Laboratory Aspects : 2024.
Fesnak, A: Gene Therapy Transfusion Medicine and Hemostasis: Clinical and Laboratory Aspects : 2024.
Mack EA, Dougher MC, Ginda AM, Cahill C, Murter M, Schell K, Tanhehco YC, Bhoj VG, Fesnak AD, Siegel DL, Kambayashi T, Aqui NA, O'Doherty U: Red cell exchange for rapid leukoreduction in adults with hyperleukocytosis and leukostasis Blood 143 (11): 1049-1054,2024.
Wang K, Tseng CY, Li Z, White C, Wang B, Levine BL, Fesnak AD: A simulation-based comparison of centralized and point-of-care supply chain strategies for autologous cell therapy Cytotherapy 25 (12): 1370-1379,2023.
Plesa G,
Brennan AL,
Levine JR,
Hasenmayer D,
Buchholz K,
Migliaccio T,
Holland D,
Colligon TA,
Mackey S,
Dai A,
Petrella J,
Ngo S,
Fesnak A,
Davis MM,
Siegel D: Multiple Efficiencies Gained by Implementing a Significantly Shorter Manufacturing Schedule for Production of CAR T Cell Products Cytotherapy 25 (6): S9,2023.
Mackey, S., Dai, A., Gong, N., McGettigan, B., Jefferson, P., Petrella, J., Gohil, M., Fesnak, A., Siegel, D., Davis, M. M., Plesa, G.: Developing and Optimizing Multicolor Flow Cytometry Methods for the Manufacturing and Release of 3-Day HuCART Products Cytotherapy 25 (6): S189-S190,2023.
Fesnak AD, Raval JS: Adverse Events of Cellular and Biotherapies AABB Technical Manual, 21st edition : 2023.
Fesnak AD, Siegel DL: Chimeric antigen receptor T cells and other cellular immunotherapies Rossi's Principles of Transfusion Medicine, Sixth Edition : 2022.
Guleria I, de Los Angeles Muñiz M, Wilgo M, Bapat A, Cui W, Hsu YS, Jeyaraman M, Muthu S, Rodriguez F, Fesnak A, Celluzzi C, Sesok-Pizzini D, Reich-Slotky R, Spitzer T.: How do I: Evaluate the safety and legitimacy of unproven cellular therapies? Transfusion 62 (3): 518-532,2022.
Frey NV, Gill S, Hwang WT, Luger SM, Martin ME, McCurdy, SR, Loren AW, Pratz KW, Perl AE, Barber-Rotenberg J, Marshall A, Ruella M, Lacey SF, Fraietta J, Fesnak A, O'brien M, Schanne T, Brogdon JL, Engels B, Levine BL, June CH, Porter DL, Hexner EO: CART22-65s Co-Administered with huCART19 in Adult Patients with Relapsed or Refractory ALL Blood 138 (Supplement 1): 469,2021.
View all publications
Academic Contact Information
3400 Spruce Street
3 Ravdin Building - R3067
Philadelphia,
PA
19104
Phone: 215-662-3325